The Economic Burden of Schizophrenia in the United States in 2013

Journal of Clinical Psychiatry, June 2016;77(6):764-71

Schizophrenia is associated with a significant economic burden where, in addition to direct health care costs, indirect and non-health care costs are strong contributors, suggesting that therapies should aim at improving not only symptom control but also cognition and functional performance, which are associated with substantial non-health care and indirect costs.